1 rich Libsyn https://www.libsyn.com 90 600 This week, we discuss a study showing promise in applying CAR-T immunotherapy in bladder cancer tumours and breakdown how scientists have uncovered spectral signatures previously misassigned in carbon materials – with Frankie Macpherson and Mason Wakley. CAR-T therapy has been a game changer for blood cancers, yet solid tumours have been largely resistant to this treatment. We discuss a new study that shows promise in applying this immunotherapy in bladder cancer tumours. And, we discuss why scientists are rethinking how they assign peaks in spectra of carbon-based materials. What does this mean for the technologies that rely on them, and do we need to rethink some long-held assumptions? &amp;nbsp; Main stories: https://www.chemistryworld.com/news/step-forward-for-car-t-therapy-as-it-shows-promise-in-solid-bladder-tumours/4024034.article https://www.chemistryworld.com/news/chemists-may-be-misassigning-defects-in-carbon-materials-study-suggests/4024018.article &amp;nbsp; Headlines: https://www.chemistryworld.com/news/copper-chains-more-than-4000-atoms-long-are-the-longest-ever-produced/4024095.article https://www.chemistryworld.com/news/hokkaido-university-graduate-student-dies-after-exposure-to-hydrofluoric-acid/4024098.article https://www.chemistryworld.com/news/sodium-batteries-durability-and-performance-boosted-by-scandium-additive/4024088.article https://www.chemistryworld.com/news/molecular-dyes-outside-of-the-srgb-colour-gamut-present-a-challenge-for-digital-chemistry/4024094.article Chemistry World Podcast https://www.chemistryworld.com/podcasts <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/42716680/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/item/42716680